Life Science Sector Bets Big on Bay State: $5.5 billion Active CAPEX Facility Investment in Massachusetts

SUGAR LAND--March 28, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The state of Massachusetts is celebrated for many things, including its natural beauty, leading academic institutions and its abundant historical sites. Not to be overlooked is its importance to the entire life science industry. From bio wet-lab incubators housing nascent biotechs, all the way up to vast commercial manufacturing complexes, the state comes up a winner in attracting the industry's capital construction dollars. Within this article: Details of a potential Pfizer (NYSE:PFE) expansion project in Andover, Massachusetts.